Rep triggered e-mails
-
Re: edirect campaign to HCP
I read in a previous post that reps that promote more than one brand to the same HCP may include attachments for more than one brand to their RTE.If the subject line, body of the e-mail and sign-off do not contain any brand name or branding whatsoever, is it necessary to include any fair balance at all? The only place a brand name would appear would be in the file name, E,g, brandxpatient supporttool.pdf. We would assume not, because there are no claims, and each tool would have the fair balance appropriate to that tool, but would appreciate confirmation.
(We are aware that branded and unbranded tools cannot be included in the same RTE).
Thanks, L. -
Re: edirect campaign to HCP
I read in a previous post that reps that promote more than one brand to the same HCP may include attachments for more than one brand to their RTE.If the subject line, body of the e-mail and sign-off do not contain any brand name or branding whatsoever, is it necessary to include any fair balance at all? The only place a brand name would appear would be in the file name, E,g, brandxpatient supporttool.pdf. We would assume not, because there are no claims, and each tool would have the fair balance appropriate to that tool, but would appreciate confirmation.
(We are aware that branded and unbranded tools cannot be included in the same RTE).
Thanks, L.Hello @Laurelea,
You are correct. If there are no brand-related claims and no reference to therapeutic use, it would be acceptable to not include fair balance within the piece if the document titles are neutral and claim-free, as per your example. For further information on naming conventions for email attachments, please see PAAB : Resources : Document names and descriptions for external use. Please note that the emails would still be subject to PAAB review as they link to advertising. For more information on the submission of email templates, please refer to Clarification regarding digitization of APS: Helping healthcare product manufacturers plan for the evolving COVID-19 operational context (in particular, the Dissemination section).
Thanks!
Danielle